Seventh cranial nerve

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Searching Images

facial nerve anatomy course branches CN7

Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Now I have rich, comprehensive content. Let me compile the full answer.

Facial Nerve (CN VII) — The Seventh Cranial Nerve

Fiber Composition

The facial nerve is a mixed nerve with five functional fiber types:
Fiber TypeFunction
Special Visceral Efferent (SVE / Branchial efferent)Motor to muscles of facial expression, stapedius, stylohyoid, posterior digastric
General Visceral Efferent (GVE / Parasympathetic)Secretomotor to lacrimal gland, nasal/palatine glands (via GSPN), submandibular & sublingual glands (via chorda tympani)
Special Afferent (SA / Taste)Taste — anterior 2/3 of tongue (chorda tympani), palate & tonsillar fossa (GSPN)
General Somatic Afferent (GSA)Sensation from skin of external auditory canal and auricle
General Visceral Afferent (GVA)Mucosa of nose, pharynx, palate

Brainstem Nuclei

Three brainstem nuclei correspond to these modalities:
  • Motor nucleus of CN VII (pons) → SVE fibers
  • Superior salivatory nucleus (pons) → GVE (parasympathetic) fibers
  • Nucleus of the solitary tract (pons/medulla) → receives taste (SA) and visceral afferent (GVA) input
The motor fibers have a distinctive intracranial loop — they curve around the abducens nucleus (CN VI), forming the facial colliculus visible on the floor of the fourth ventricle.

Course

1. Posterior Cranial Fossa

Emerges at the pontomedullary junction as two roots:
  • A large motor root
  • A smaller nervus intermedius (sensory + parasympathetic root)
Both cross the posterior cranial fossa and enter the internal acoustic meatus (IAM) of the petrous temporal bone, alongside CN VIII and the labyrinthine artery.

2. Within the Temporal Bone — The Fallopian (Facial) Canal

Facial nerve in the temporal bone showing geniculate ganglion, greater petrosal nerve, nerve to stapedius, and chorda tympani
Facial nerve in the temporal bone (A) and course of chorda tympani (B) — Gray's Anatomy for Students
At the distal IAM, the two roots fuse and the nerve enters the fallopian canal through three segments:
SegmentLocationFeatures
LabyrinthineFundus of IAC → geniculate ganglionShortest, narrowest; no fibrous sheath; runs superior to cochlea
Tympanic (horizontal)Geniculate ganglion → pyramidal eminence1st genu (sharp posterior turn); bulges on medial wall of middle ear; overlies oval window
Mastoid (vertical)Pyramidal eminence → stylomastoid foramen2nd genu at pyramidal eminence; gives off nerve to stapedius and chorda tympani
The nerve exits the skull through the stylomastoid foramen.

3. Extracranial Course

After exiting the stylomastoid foramen, the nerve enters the parotid gland, divides into upper (temporofacial) and lower (cervicofacial) trunks, and ramifies into five terminal branches that emerge from the borders of the gland:
  1. Temporal — frontalis, orbicularis oculi (upper)
  2. Zygomatic — orbicularis oculi (lower), zygomaticus
  3. Buccal — buccinator, orbicularis oris
  4. Marginal mandibular — depressors of lip/chin
  5. Cervical — platysma
(Mnemonic: Two Zealous Bobbies Make Coffee — or "Ten Zebras Bit My Calf")

Branches and Their Functions

BranchOriginCarriesFunction
Greater petrosal nerve (GSPN)Geniculate ganglionPreganglionic parasympathetic + taste→ pterygopalatine ganglion → lacrimal gland, nasal/palatine glands
Nerve to stapediusMastoid segmentMotorDampens ossicular chain (lesion → hyperacusis)
Chorda tympaniMastoid segment, just above stylomastoid foramenPreganglionic parasympathetic + tasteCrosses middle ear between malleus and incus; exits via petrotympanic fissure; joins lingual nerve → submandibular ganglion, taste from anterior 2/3 tongue
Posterior auricular nerveJust after stylomastoid foramenMotorOccipitalis, posterior auricular muscle
Nerve to stylohyoid & posterior digastricJust after stylomastoid foramenMotorStylohyoid & posterior belly of digastric

Localizing Lesions

Because different branches leave the nerve at different levels, the pattern of deficits localizes the lesion:
SiteDeficits
Motor cortex / internal capsule (UMN)Contralateral lower face weakness only (upper face spared — bilateral cortical supply)
Facial nucleus / nerve in pons (LMN)Ipsilateral entire face weakness
Proximal to geniculate ganglionEntire ipsilateral face palsy + loss of lacrimation + loss of taste anterior 2/3 tongue + hyperacusis
Below geniculate ganglion, above chorda tympaniEntire ipsilateral face palsy + loss of taste + hyperacusis; lacrimation intact
Stylomastoid foramen (Bell's palsy)Entire ipsilateral face palsy only; taste, lacrimation, hearing intact (all branches already given off)
Bell phenomenon: on attempted eye closure with complete palsy, the eye rolls upward — the globe is seen because the eyelid cannot close.

Bell's Palsy

The most common cause of acute facial paralysis (~23/100,000/year). Caused predominantly by HSV-1 reactivation in the geniculate ganglion (HSV-1 DNA isolated by PCR in endoneurial fluid in the majority of surgical cases). Risk factors include diabetes, hypertension, and possibly late pregnancy/postpartum. MRI shows enhancement of the labyrinthine segment and geniculate ganglion with normal HRCT.
Ramsay Hunt syndrome (herpes zoster oticus): VZV reactivation at the geniculate ganglion — facial palsy + ipsilateral ear/auricular vesicles ± hearing loss/vertigo.

Clinical Pearls

  • The intimate relationship of CN VII with the parotid gland makes parotidectomy technically demanding; perineural invasion by parotid malignancy can track proximally along the nerve.
  • Facial nerve schwannomas present with gradual-onset facial paresis + hearing loss; T1 MRI shows an enhancing, expansile mass along the nerve's course with canal enlargement on HRCT.
  • The labyrinthine segment is the narrowest part of the fallopian canal — swelling here (as in Bell's palsy or Ramsay Hunt) readily compresses the nerve.
  • The geniculate ganglion is dehiscent (paper-thin overlying bone) in ~25% of ears, a surgical hazard during middle fossa approaches.

Sources: Gray's Anatomy for Students; Adams and Victor's Principles of Neurology, 12th ed.; Cummings Otolaryngology Head and Neck Surgery; Kanski's Clinical Ophthalmology

Mini mental state examination

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

mini mental state examination MMSE scoring sheet

I now have comprehensive content from multiple authoritative textbooks. Here is the full answer:

Mini-Mental State Examination (MMSE)

Overview

The MMSE was developed by Folstein et al. (1975) as a standardized, 30-point bedside screening tool for cognitive function. It remains one of the most widely used mental status examinations across clinical and research settings — community samples, hospitals, specialty clinics — and across a broad range of neurological and psychiatric conditions including dementia, stroke, and depression. Administration typically takes less than 10 minutes and can be performed by trained clinic staff.

Domains Assessed

The MMSE evaluates 11 items across the following cognitive domains:
DomainTasksMax Points
Orientation to TimeYear, season, month, date, day5
Orientation to PlaceCountry, county/state, town, hospital, ward/floor5
RegistrationName 3 objects; patient repeats them3
Attention & CalculationSerial 7s (subtract 7 from 100, five times) or spell "WORLD" backwards5
RecallRecall the 3 objects from Registration3
Language — NamingName a pencil and a watch2
Language — RepetitionRepeat "No ifs, ands, or buts"1
Language — 3-Stage CommandTake paper in right hand, fold it, put it on the floor3
ReadingRead and obey "Close your eyes"1
WritingWrite a sentence spontaneously1
Construction (Visuospatial)Copy intersecting pentagons1
TOTAL30

Scoring and Interpretation

ScoreInterpretation
27–30Normal (no cognitive impairment)
24–26Borderline / mild cognitive impairment
18–23Mild dementia
10–17Moderate dementia
< 10Severe dementia
Key threshold: Scores below 24 are generally considered "impaired," though this cutoff must be adjusted for age and education.

Effect of Demographic Variables

Age and education systematically influence MMSE scores, and this is a critical limitation:
  • Highly educated patients with early Alzheimer disease may score in the normal range (false negatives)
  • Low-education individuals may score in the impaired range without true cognitive impairment (false positives)
Normative data from the Epidemiologic Catchment Area study show, for example, that the mean MMSE score for adults with 0–4 years of education is ~22, while those with 9+ years of education average ~29 — a difference of ~7 points on the same 30-point scale.
Cutoff scores should always be adjusted for age and education before concluding impairment is present.

Uses

  • Screening for cognitive impairment (dementia, delirium, stroke effects)
  • Serial monitoring — tracking disease progression or treatment response over time
  • Severity staging of dementia
  • Communication — widely adopted so clinicians share an intuitive sense of what a given score means functionally
The MMSE is not used to make a formal diagnosis, and it does not replace comprehensive neuropsychological testing.

Limitations

  1. No executive function assessment — other than serial sevens, frontal/executive deficits are not captured; this is a major gap since executive dysfunction is a hallmark of vascular dementia and early Alzheimer disease
  2. Insensitive to mild cognitive impairment (MCI) — particularly in educated individuals
  3. Insensitive to noncortical dementias (e.g., Parkinson's dementia, vascular dementia)
  4. Education and age bias (as above)
  5. Copyright — the MMSE is a copyrighted instrument (PAR Inc.) requiring purchase for legal clinical or research use

Modified MMSE (3MS)

Developed by Teng and Chui (1987) to address MMSE shortcomings. Key differences:
  • 14 items (vs. 11)
  • Adds orientation to self, verbal fluency, recognition memory, and executive function (similarities)
  • 100-point scoring range (vs. 30) — more sensitive to detecting change
  • Impairment cutoff: ≤ 77
  • A decline of ≥ 5 points over 5–10 years indicates clinically meaningful cognitive decline
  • Age- and education-corrected norms available; regression-based prediction formulas allow more accurate change detection

Comparison with MoCA

FeatureMMSEMoCA
Score range0–300–30
Time< 10 min< 10 min
Executive functionMinimalYes (trail-making, abstraction, clock drawing)
VisuospatialPentagons onlyClock, cube
Target populationModerate-severe dementiaMCI detection
Impairment cutoff< 24< 26
Sensitivity for MCILow90%
Sensitivity for ADModerate100%
CostCopyrighted (purchase required)Free (certification now required in most settings)
The MoCA (Nasreddine et al., 2005) was designed specifically to overcome the MMSE's insensitivity to MCI and adds probing of executive functioning, working memory, and visuospatial abilities — making it the preferred screening tool when early or subtle cognitive impairment is suspected.

Sources: Bradley and Daroff's Neurology in Clinical Practice; Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Kaplan and Sadock's Synopsis of Psychiatry

Bundle branch block ecg

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching Images

right bundle branch block left bundle branch block ECG pattern comparison

Reading File
Reading File
Loading Image
Loading Image
Loading Image
Loading Image
Excellent — I have comprehensive content and high-quality ECG images from Harrison's and Goldman-Cecil. Here is the full answer:

Bundle Branch Block — ECG

Anatomy & Mechanism

The His-Purkinje system divides into:
  • Right bundle branch (RBB) → depolarizes the right ventricle
  • Left bundle branch (LBB) → splits into anterior fascicle (left anterior), posterior fascicle (left posterior), and a septal fascicle
Normal ventricular activation: the impulse travels simultaneously down both bundles, depolarizing both ventricles in ~80–100 ms (narrow QRS).
When a bundle branch is blocked, the affected ventricle is depolarized late via slow cell-to-cell conduction rather than rapid Purkinje conduction → wide QRS ≥ 120 ms and abnormal morphology.

General ECG Principles in BBB

  1. QRS duration ≥ 120 ms (complete BBB) or 110–119 ms (incomplete)
  2. Secondary ST-T changes — T wave is always opposite in polarity to the last deflection of the QRS (discordance). This is a normal consequence of altered depolarization sequence — not a primary repolarization abnormality
  3. The "William Morrow" mnemonic: WiLLiaM (LBBB: W in V1, M in V6) / MaRRoW (RBBB: M in V1, W in V6) — see morphology below

Right Bundle Branch Block (RBBB)

ECG Criteria (complete RBBB)

FeatureFinding
QRS duration≥ 120 ms
V1 morphologyrSR' (or rsR', RSR') — classic "rabbit ears"
V5–V6 morphologyWide, slurred terminal S wave (qRS)
Lead I / aVLWide, slurred S wave
T-waveInverted/negative in V1–V2 (secondary change — discordant with terminal R')
AxisUsually normal; septal Q waves (normal septal activation preserved)

Mechanism

  • Left ventricle activates normally (first deflection — small r in V1 from normal septal activation)
  • Right ventricle activates late, via spread from the left → terminal vector directed rightward and anteriorly → R' in V1, slurred S in lateral leads

Incomplete RBBB

  • QRS 110–119 ms with RSR' in V1–V2, but R' is not taller than the S wave amplitude — often a normal variant, especially in young people and athletes

Left Bundle Branch Block (LBBB)

ECG Criteria (complete LBBB)

FeatureFinding
QRS duration≥ 120 ms
V1 morphologyBroad rS or QS (dominant deep S, often with notching)
V5–V6 / I / aVLBroad, tall, often notched R wave (no Q wave) — "M-shaped"
Septal Q wavesAbsent in I, aVL, V5–V6 (septal activation reversed)
T-waveInverted in I, aVL, V5–V6; upright in V1–V2 (discordant)
AxisNormal or leftward

Mechanism

  • Septal activation reverses: septum activates right-to-left → no initial q wave in lateral leads
  • Left ventricle depolarizes late via slow spread from right → broad, notched R waves in lateral leads and a wide QS/rS in V1

Waveform Comparison — Normal vs. RBBB vs. LBBB

Comparison of typical QRS-T patterns in RBBB and LBBB with normal in V1 and V6
Harrison's Principles of Internal Medicine: RBBB shows rSR' in V1 with discordant T inversion; LBBB shows broad QS in V1 and broad notched R in V6 with discordant T inversion

12-Lead ECG Examples

RBBB (left anterior fascicular block + RBBB = bifascicular block):
12-lead ECG of RBBB with left anterior fascicular block
Goldman-Cecil Medicine: RBBB — rsR' in V1, wide S in V5; normal axis; discordant ST-T in right precordials
Left posterior fascicular block and LBBB:
12-lead ECG showing left posterior fascicular block (D) and LBBB (E)
Goldman-Cecil Medicine: (D) Left posterior fascicular block with right axis deviation; (E) LBBB — broad notched R in lateral leads, deep QS in V1–V3, discordant ST-T throughout

Fascicular Blocks (Hemiblocks)

These block the left bundle's sub-fascicles. QRS is not significantly widened (<120 ms) but the frontal axis shifts:
BlockAxisV leadsFeatures
Left Anterior Fascicular Block (LAFB)≤ −45° (marked LAD)Late precordial transitionSmall q in I, aVL; small r in II, III, aVF
Left Posterior Fascicular Block (LPFB)≥ +110° (RAD)Delayed R progressionSmall r in I, aVL; q in II, III, aVF — rare; must exclude other causes of RAD

Bifascicular & Trifascicular Block

PatternComponentsRisk
Bifascicular blockRBBB + LAFB (most common) or RBBB + LPFB~6%/year risk of complete AV block
Trifascicular blockBifascicular + long PR interval (1st-degree AV block)High risk for complete AV block
Alternating BBBRBBB on some beats, LBBB on othersClass I indication for permanent pacing

BBB in Acute MI

LBBB alters ST-T morphology throughout the precordium, masking ST-elevation MI. Use Sgarbossa criteria to identify MI in LBBB:
CriterionPoints
ST elevation ≥ 1 mm concordant with QRS (same direction)5
ST depression ≥ 1 mm in V1, V2, or V3 (concordant with negative QRS)3
ST elevation ≥ 5 mm discordant with QRS (opposite direction — normally expected but excessively large)2
Score ≥ 3 = likely acute MI. New LBBB in the setting of chest pain = STEMI equivalent until proven otherwise — treat with emergent reperfusion.
Risk of progression to complete heart block in BBB during MI:
  • RBBB + LAFB → 27%; RBBB + LPFB → 29%; alternating BBB → 44%

Causes

RBBBLBBB
Can be normal (no structural disease)Almost always signifies structural disease
Atrial septal defectCoronary artery disease / ischemic cardiomyopathy
Pulmonary hypertension / embolismHypertensive heart disease
Right heart diseaseAortic valve disease / post-TAVR
Congenital heart diseaseDilated cardiomyopathy
Brugada pattern (RBBB morphology + STE in V1–V3)Fibrosis of conduction system
LBBB is often a marker of four conditions with increased cardiovascular morbidity: CAD, hypertension, aortic valve disease, and cardiomyopathy. LBBB-associated ventricular dyssynchrony worsens heart failure; these patients benefit from cardiac resynchronization therapy (CRT / biventricular pacing).

Rate-Related BBB

BBB may be intermittent, appearing only when the heart rate exceeds a critical threshold — most commonly phase 3 (tachycardia-dependent) aberrancy. This is distinct from fixed (chronic) BBB.

Sources: Harrison's Principles of Internal Medicine 22nd ed.; Goldman-Cecil Medicine; Fuster and Hurst's The Heart, 15th ed.; Roberts and Hedges' Clinical Procedures in Emergency Medicine; Pfenninger and Fowler's Procedures for Primary Care

Syncope

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive material across all domains. Here is the complete answer:

Syncope

Definition

Syncope is an abrupt, transient, and complete loss of consciousness with inability to maintain postural tone, followed by spontaneous, complete recovery. The underlying mechanism is always transient cerebral hypoperfusion. Episodes that are incomplete (i.e., lightheadedness without loss of consciousness) are termed presyncope and carry similar clinical significance.
Syncope must be distinguished from cardiac arrest (loss of consciousness without spontaneous recovery) and from seizure, hypoglycemia, and psychogenic pseudo-syncope.

Epidemiology

  • Lifetime prevalence: ~40%; recurrence rate: 14%
  • Accounts for 1–3% of ED visits and 6% of hospital admissions
  • Annual cost of syncope hospitalizations: $1.7 billion ($26,000/hospitalization)
  • Incidence increases with age; in the Framingham Study: 3.0% in men, 3.5% in women over 26 years
  • Cause remains unknown in up to 50% of patients despite extensive evaluation

Pathophysiology

The common final pathway is a fall in cerebral perfusion below the threshold for consciousness. This can result from:
  1. Reduced cardiac output (arrhythmia, obstruction)
  2. Reduced systemic vascular resistance (vasodilation)
  3. Reduced venous return / preload (hypovolemia, venous pooling)
  4. Combinations of the above

Classification & Causes

1. Reflex (Neurally Mediated) Syncope — Most Common

Caused by inappropriate vasodilation, bradycardia, or both due to sudden failure of autonomic tone.
TypeMechanism / TriggerFeatures
Vasovagal (neurocardiogenic)Prolonged standing, emotional stress, pain, venipuncture, warm/crowded environmentProdrome: nausea, pallor, diaphoresis, lightheadedness, warmth, blurred vision; more common in young people
Carotid sinus syndromePressure on carotid sinus (shaving, tight collar, head turning) → sinus arrest/AV block (cardioinhibitory) and/or vasodilation (vasodepressor)More common in men ≥50 years; positive carotid sinus massage: pause ≥3 s and/or SBP drop ≥50 mmHg
SituationalMicturition, defecation, coughing, swallowing, laughing, sneezing, post-exercise, postprandialClosely linked to a specific provoking action
Mechanism of vasovagal syncope: venous pooling in dependent areas → decreased venous return → reflex increase in myocardial contractility → activation of ventricular mechanoreceptors (normally fired only during stretch) → paradoxic decrease in sympathetic outflow (hypotension) + increased vagal tone (bradycardia → sometimes asystole on tilt-table).

2. Orthostatic Syncope

Defined as a fall in SBP ≥20 mmHg and/or DBP ≥10 mmHg within 3 minutes of standing.
SubtypeExamples
HypovolemiaDehydration, hemorrhage, Addison disease
Drug-inducedAntihypertensives (β-blockers, CCBs, nitrates, ACEi/ARBs, diuretics), antidepressants (TCAs, MAOIs, SSRIs), antipsychotics, levodopa, opioids, alcohol
Autonomic dysfunctionDiabetes, Parkinson disease, multisystem atrophy, amyloidosis
Deconditioning / prolonged bed rest

3. Cardiac Syncope — Highest Mortality

Cardiac syncope from cardiovascular disorders is associated with ~50% mortality over 5 years and ~30% in the first year. Must be actively excluded.
Arrhythmic causes:
  • Sinus node dysfunction (sinus bradycardia < 40 bpm, sinus pauses > 3 s)
  • AV block (Mobitz II, complete heart block)
  • Supraventricular tachycardias (SVT, AF/flutter with rapid ventricular response)
  • Ventricular tachycardia / fibrillation
  • Long QT syndrome (congenital or acquired), Brugada syndrome, CPVT
  • Pacemaker dysfunction
Structural / obstructive causes:
  • Aortic stenosis (syncope = severe obstruction, poor prognosis)
  • Hypertrophic cardiomyopathy (exertional syncope = high SCD risk)
  • Mitral stenosis
  • Atrial myxoma
  • Prosthetic valve dysfunction
  • Pulmonary embolism / pulmonary hypertension
  • Cardiac tamponade
  • Acute MI / ischemia

4. Cerebrovascular

  • Vertebrobasilar TIA / insufficiency — syncope nearly always preceded by vertigo, diplopia, dysarthria, ataxia
  • Subclavian steal syndrome — upper extremity exertion shunts blood retrograde via vertebral artery
  • Occlusive disease (Takayasu arteritis, aortic arch syndrome)
  • Klippel-Feil deformity / cervical spondylosis (vertebral artery compression)

Syncope vs. Seizure — Key Differentiators

FeatureSyncopeSeizure
Posture-relatedCommonNo
Skin colorPallorCyanosis or normal
DiaphoresisCommonRare
ProdromeOften prolonged (minutes)Brief aura
ConvulsionsRare; minor irregular twitchingCommon; rhythmic jerks
Tongue bitingNoCommon
Urinary incontinenceRareCommon
Postictal confusionRareCommon
Postictal headacheNoCommon
ECG/EEGNormalOften abnormal
Syncope has been misdiagnosed as seizure in 38% of patients who continued to have episodes despite anticonvulsant therapy — a critical clinical trap.

Clinical Approach

History

Key clinical context questions:
  • Position at onset — lying/sitting/standing (orthostatic vs. cardiac)?
  • Activity — exertional (cardiac outflow obstruction, arrhythmia, ARVC, CPVT) vs. at rest?
  • Prodrome — nausea/diaphoresis (vasovagal) vs. palpitations (arrhythmia) vs. none (cardiac, elderly)?
  • Duration — brief and sudden = cardiac; gradual onset with prodrome = vasovagal
  • Recovery — postictal confusion? (seizure); rapid and complete = syncope
  • Triggers — specific situational triggers, head turning (carotid sinus), venipuncture, crowds
  • Medications — QT-prolonging drugs, antihypertensives, antiparkinsonian agents
  • Family history — sudden cardiac death (long QT, HCM, Brugada, ARVC)

Physical Examination

  • Orthostatic BP (only useful if symptoms reproduced on standing)
  • Blood pressure in both arms (subclavian steal, Takayasu)
  • Heart rate during arrhythmia: >140 bpm = likely not sinus; <40 bpm = likely complete AV block
  • Cardiac auscultation — murmurs (aortic stenosis: systolic ejection murmur; HCM: dynamic murmur)
  • Signs of heart failure; new neurological deficit (not syncope — consider stroke/SAH)
  • Carotid sinus massage (older patients, not routine in ED)

Investigations

ECG (12-lead) — Recommended in nearly all cases

ECG findings diagnostic of arrhythmic syncope:
  • Sinus bradycardia < 40 bpm or pause > 3 s
  • Mobitz II second-degree AV block
  • Complete (third-degree) heart block
  • Sustained SVT or VT
ECG findings raising concern for underlying cause:
  • Prolonged QTc → long QT syndrome
  • Short PR + delta wave → WPW (pre-excitation)
  • RBBB + ST elevation V1–V3 → Brugada syndrome
  • RV strain pattern → PE
  • New LBBB → rule out STEMI
  • Epsilon waves / RBBB + T-wave inversions V1–V3 → ARVC

Additional Testing

TestWhen
Holter monitor (24–48 h)Suspected arrhythmia, frequent episodes
Event recorder (weeks)Infrequent episodes
Implantable loop recorder (ILR)Very infrequent episodes (weeks–months); diagnostic in ~2/3 of unexplained syncope
EchocardiogramSuspected structural heart disease
Cardiac MRIARVC, HCM, inconclusive echo
Exercise stress testExertional syncope
Tilt-table testSuspected neurocardiogenic or orthostatic syncope
Electrophysiology study (EPS)HV interval ≥70 ms or infranodal block → pacing indication
TroponinOnly if ACS is suspected
BNP/NT-proBNPPrognostic utility for 30-day adverse cardiac events
CT headOnly if head trauma after syncope, or new neurological deficit
Routine labs (CBC, electrolytes, glucose) are not supported by evidence for standard syncope evaluation.

Prognosis

CauseMortality
Cardiac syncope~50% at 5 years; ~30% in first year; all-cause mortality doubled vs. general population
Non-cardiac (reflex/orthostatic)~30% at 5 years; <10% in first year; more benign course
Unexplained syncope6–10% at 3 years; 24% at 5 years
Vasovagal / reflexBenign; recurrence affects quality of life
Syncope is an ominous sign in HCM (high SCD risk) and in aortic stenosis (severe obstruction, < 2–3 year survival without intervention).

Management

Reflex (Vasovagal) Syncope

  • Non-pharmacologic first: education, avoid triggers, physical counterpressure maneuvers (leg crossing, arm tensing), liberal salt and fluid intake, compression stockings, tilt training
  • Midodrine (α-agonist) — FDA-approved for orthostatic hypotension; reduces vasovagal recurrence
  • SSRIs — randomized controlled trial evidence for prevention of recurrent neurocardiogenic syncope
  • Fludrocortisone — volume expansion; evidence mixed
  • Ivabradine — useful in POTS and neurocardiogenic syncope refractory to β-blockers
  • Pyridostigmine — acetylcholinesterase inhibitor; prevents orthostatic BP falls without worsening supine hypertension
  • Cardiac pacing — only in cardioinhibitory carotid sinus syndrome with documented pause; not routinely for vasovagal

Orthostatic Syncope

  • Treat underlying cause; review/stop offending medications
  • Volume expansion (fluids, salt, fludrocortisone)
  • Midodrine, droxidopa (approved for neurogenic orthostatic hypotension)
  • Head-of-bed elevation (reduces nocturnal natriuresis)

Cardiac Syncope

  • Arrhythmic: permanent pacemaker (bradycardia, heart block); ICD (VT/VF, Brugada, long QT, HCM); catheter ablation (SVT, VT); antiarrhythmic drugs
  • Structural: treat underlying disease (valve surgery/TAVR for AS; septal reduction for HCM; anticoagulation for PE)
  • Bifascicular block with syncope + HV ≥70 ms on EPS: permanent pacing (Class I indication)
  • Alternating BBB: pacemaker regardless of symptoms (Class I)

Sources: Fuster and Hurst's The Heart, 15th ed.; Bradley and Daroff's Neurology in Clinical Practice; Rosen's Emergency Medicine; Tintinalli's Emergency Medicine
This is a shared conversation. Sign in to Orris to start your own chat.